ACE2 Archives - Top Personal Health

Study explores how human ACE2 variants can modify SARS-CoV-2 binding

July 6, 2021 ACE2, Angiot, SARS, SARS-CoV-2

A recent tour-de-force study by researchers from the United Kingdom reveals variants of the human angiotensin-converting enzyme 2 (ACE2) that

Health News

The "key" to vaccine development depends on virus’ binding to human cells

May 11, 2021 ACE2, an, Angiotensin, vaccine

New variants of the SARS-CoV-2 virus most likely will necessitate the development of more vaccine options in the years ahead,

Health News

Researchers develop broad-spectrum SARS-CoV-2 RBD-based vaccine

April 13, 2021 ACE2, Angiotensin, Angiotensin-Converting Enzyme 2, antibodies, antibody, cell, Coronavirus, Coronavirus Disease COVID-19, efficacy, enzyme, Nanoparticle, Nanoparticles, pandemic, pathogen, protein, receptor, respiratory, SARS, SARS-CoV-2, Severe Acute Respiratory, Severe Acute Respiratory Syndrome, Spike Protein, syndrome:, vaccine, virus

Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pathogen. Three emergent SARS-like diseases

Health News

Are marine mammals are at risk of COVID-19?

April 3, 2021 ACE2, Coronavirus, Coronavirus Disease COVID-19, enzyme, lungs, pandemic, pH, research, respiratory, SARS, SARS-CoV-2, Severe Acute Respiratory, Severe Acute Respiratory Syndrome, syndrome:, virus

As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to circulate around the world, ecologists have become increasingly concerned about

Health News

New research proposes innovative antibody-based treatment to prevent SARS-CoV-2 viral entry

March 17, 2021 ACE2, Angiotensin, Angiotensin-Converting Enzyme 2, antibodies, antibody, cell, Coronavirus, Coronavirus Disease COVID-19, enzyme, protein, Pseudovirus, receptor, research, respiratory, SARS, SARS-CoV-2, Severe Acute Respiratory, Severe Acute Respiratory Syndrome, Spike Protein, syndrome:

A brief report by researchers at the University of Virginia, USA, proposes using an antibody-based treatment with a plug-and-play strategy

Health News

Clonally expanded plasma cell lineages in SARS-CoV-2 produce specific neutralizing antibodies

February 16, 2021 ACE2, Angiotensin, Angiotensin-Converting Enzyme 2, antibodies, antibody, Antigen, Blood, cell, Cell Membrane, Convalescent Plasma, Coronavirus, Coronavirus Disease COVID-19, Cytometry, enzyme, Flow Cytometry, genes, genome, Genome Editing, Germline, Glycoprotein, Immune Response, Immunoglobulin, pathogen, protein, receptor, research, respiratory, SARS, SARS-CoV-2, Severe Acute Respiratory, Severe Acute Respiratory Syndrome, syndrome:, virus

The immune response to infection by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of the ongoing coronavirus

Health News

Second dose of Pfizer-BioNTech COVID-19 vaccine may not benefit previously infected individuals

February 11, 2021 ACE2, antibodies, antibody, Antigen, cell, Coronavirus, Coronavirus Disease COVID-19, medicine, protein, receptor, research, respiratory, SARS, SARS-CoV-2, Severe Acute Respiratory, Severe Acute Respiratory Syndrome, Spike Protein, syndrome:, vaccine

Researchers at the NYU Grossman School of Medicine have shown that a second dose of the Pfizer-BioNTech BNT162b2 vaccine may

Health News

Zinc supplementation bolsters repurposed antivirals against SARS-CoV-2

February 6, 2021 ACE2, Angiotensin, Angiotensin-Converting Enzyme 2, cell, Coronavirus, Coronavirus Disease COVID-19, Cysteine, dexamethasone, Drugs, efficacy, enzyme, Hydrogen Peroxide, in vitro, Mortality, oxygen, pandemic, pathogen, protein, Protein Expression, receptor, Renin, respiratory, SARS, SARS-CoV-2, Severe Acute Respiratory, Severe Acute Respiratory Syndrome, Spike Protein, syndrome:, virus, Zinc

Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)